Zinc-alpha-2-glycoprotein

BE0002857ProteinHumansAZGP1

Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. It is acted on by 2 drugs in DrugBank.

Gene name: AZGP1
UniProtKB entry: P25311Swiss-Prot
Cellular location: Secreted
Residues / weight: 298 residues · 34,259 Da
Also known as: ZAG · Zn-alpha-2-glycoprotein · Zn-alpha-2-GP · ZNGP1

Resolves to

Protein

UniProtP25311UniProt nameZA2G_HUMAN

Gene

HGNCHGNC:910NCBI Gene563GeneCardsAZGP1

Pharmacology

KEGGhsa:563

Structure

PDB1T7VPDB1T7WPDB1T7X

Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action

4GO termsFunction, process and component, as structured annotations

2Pfam domainsDomain architecture mapped to Pfam families and clans

24+ReferencesStructured and connected to the statements they support

Which approved drugs act on Zinc-alpha-2-glycoprotein, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account